Industry Developments
Market Insights
on
6 Nov 2026
AI can now propose a molecule faster than a chemist can evaluate one. Most R&D organisations still haven't decided whose job it is to say yes.
on
18 Mar 2026
Using machine learning to identify responsive trial participants reduces patient drop-out and de-risks development timelines. We explore the data-fluent leaders driving this shift.
RSA Viewpoints
on
2 Nov 2026
A briefing for biotech boards, executives and investors
Real-World Health Data
30 Oct 2026
on
21 Oct 2026
Why capable healthcare technology produces so little change - and how the people inside the system can alter the bargain
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 40 40" xmlns="http://www.w3.org/2000/svg"><path d="M 40 2.857 L 40 37.143 C 40 37.901 39.699 38.627 39.163 39.163 C 38.627 39.699 37.901 40 37.143 40 L 2.857 40 C 2.099 40 1.373 39.699 0.837 39.163 C 0.301 38.627 0 37.901 0 37.143 L 0 2.857 C 0 2.099 0.301 1.373 0.837 0.837 C 1.373 0.301 2.099 0 2.857 0 L 37.143 0 C 37.901 0 38.627 0.301 39.163 0.837 C 39.699 1.373 40 2.099 40 2.857 Z M 11.429 14.286 L 5.714 14.286 L 5.714 34.286 L 11.429 34.286 Z M 12.143 8.571 C 12.143 7.624 11.767 6.716 11.097 6.046 C 10.427 5.376 9.519 5 8.571 5 C 7.624 5 6.716 5.376 6.046 6.046 C 5.376 6.716 5 7.624 5 8.571 C 5 9.519 5.376 10.427 6.046 11.097 C 6.716 11.767 7.624 12.143 8.571 12.143 C 9.519 12.143 10.427 11.767 11.097 11.097 C 11.767 10.427 12.143 9.519 12.143 8.571 Z M 34.286 23.686 C 34.286 17.4 32.2 13.714 26.114 13.714 C 24.844 13.714 23.593 14.027 22.472 14.625 C 21.351 15.223 20.394 16.088 19.686 17.143 L 19.686 14.286 L 14.286 14.286 L 14.286 34.286 L 20 34.286 L 20 24.943 C 19.925 24.265 19.99 23.578 20.192 22.927 C 20.394 22.275 20.727 21.672 21.172 21.154 C 21.617 20.637 22.164 20.217 22.778 19.92 C 23.392 19.623 24.061 19.456 24.743 19.429 C 28.057 19.429 28.572 22.686 28.572 24.943 L 28.572 34.286 L 34.286 34.286 Z" fill="rgb(10, 102, 194)" height="40px" id="rtqO1NEDt" width="40px"/></svg>)
